Allarity Therapeutics, Inc.
ALLR
$1.28
$0.032.47%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 48.81% | 51.94% | 54.19% | 18.49% | -106.98% |
| Total Depreciation and Amortization | -196.55% | -377.78% | -244.44% | -217.65% | 38.10% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -68.82% | -71.81% | -70.33% | -84.55% | 297.47% |
| Change in Net Operating Assets | -59.82% | -152.40% | -9,115.87% | 95.93% | -391.88% |
| Cash from Operations | 18.47% | 10.79% | 14.59% | 6.54% | -6.76% |
| Capital Expenditure | 75.84% | 75.84% | 97.32% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 75.84% | 75.84% | 97.32% | -- | -- |
| Total Debt Issued | -- | -- | -- | -100.00% | -100.00% |
| Total Debt Repaid | -- | -- | -- | 100.00% | 100.00% |
| Issuance of Common Stock | -87.04% | -94.43% | -62.95% | -47.00% | -48.00% |
| Repurchase of Common Stock | 65.42% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Preferred Stock | -- | -- | -- | 100.00% | 30.00% |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 23.35% | -58.66% | -71.06% | -54.28% | -48.99% |
| Foreign Exchange rate Adjustments | 157.58% | -94.25% | -396.44% | -717.26% | -1,960.82% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 741.06% | -92.30% | -125.02% | -109.19% | -107.61% |